{"disease":{"id":"hpv-related-oropharynx-squamous-cell-carcinoma","name":"hpv related oropharynx squamous cell carcinoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06702033","title":"The Minimalist Trial-2","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":142,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT05608369","title":"Vorinostat in Combination With Chemoradiation in Locally Advanced HPV Negative HNSCC","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Case Comprehensive Cancer Center","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}